Skip to main content
. Author manuscript; available in PMC: 2021 Feb 19.
Published in final edited form as: Nicotine Tob Res. 2021 Feb 16;23(3):573–583. doi: 10.1093/ntr/ntaa110

Table 2.

Weighted TSNA Geometric Mean (GM) Concentrations (ng/g Creatinine) and Detection Rate (DR) by Tobacco Use Status in PATH Study Wave 1

Analyte NNAL
NNN
NAT
NAB
N GM [95% CI] DR
(%)
N GM [95% CI] DR
(%)
N GM [95% CI] DR
(%)
N GM [95% CI] DR
(%)
All users 8882 93.0 [85.9, 100.2] 96 8642 8.0 [7.7, 8.4] 68 8805 48.5 [45.1, 51.9] 75 8871 9.2 [8.7, 9.7] 72
Every day Combustible 3176 285.4 [267.9, 303.0] 100 3060 13.8 [13.0, 14.6] 91 3140 125.2 [116.2, 134.1] 96 3167 19.6 [18.2, 21.0] 93
Smokeless 355 993.3 [839.2, 1147.3] 100 339 33.8 [29.3, 38.4] 94 349 452.6 [376.0, 529.2] 97 355 41.6 [34.7, 48.4] 96
E-Cig 152 6.3 [4.7, 7.9] 93 148 5.2 [4.3, 6.0] 57 152 4.5 [3.8, 5.1] 17a 152 1.7 [1.4, 1.9] 22a
Poly 1983 278.6 [254.9, 302.2] 100 1945 12.9 [12.1, 13.8] 88 1964 130.3 [118.4, 142.2] 93 1979 20.5 [18.8, 22.2] 92
Intermittent Combustible 2400 13.0 [11.4, 14.6] 89 2352 3.1 [2.9, 3.3] 29a 2388 9.1 [8.2, 9.9] 41 2403 2.5 [2.3, 2.7] 38a
Smokeless 121 100.9 [40.7, 161.2]b 95 118 7.4 [4.4, 10.4] 53 121 39.1 [17.3, 60.9] 65 121 6.3 [3.6, 9.1] 63
E-Cig 106 3.8 [2.3, 5.2] 85 104 2.2 [1.9, 2.6] 13a 105 3.4 [2.7, 4.1] 11a 106 1.2 [1.0, 1.4] 10a
Poly 589 22.1 [16.6, 27.7] 95 576 3.3 [2.9, 3.7] 35a 586 12.8 [10.1, 15.5] 49 588 3.1 [2.6, 3.6] 44
Nonusers 2122 1.0 [0.9, 1.1] 62 2111 2.0 [1.9, 2.1] 3a 2114 3.0 [2.8, 3.2] 4a 2125 1.1 [1.0, 1.2] 5a
Former 559 2.1 [1.6, 2.6] 83 554 2.2 [1.9, 2.5] 7a 556 3.7 [3.2, 4.3] 11a 560 1.3 [1.1, 1.5] 12a
Never 1563 0.9 [0.8, 1.0] 54 1557 1.9 [1.8, 2.0] 1a 1558 2.9 [2.7, 3.1] 2a 1565 1.1 [1.0, 1.1] 3a
Every day exclusive cigarette Usersc 2037 300.9 [277.8, 324.0] 100 1942 14.9 [13.8, 16.0] 93 2015 141.0 [128.4, 153.6] 98 2030 21.3 [19.4, 23.2] 95
Intermittent exclusive cigarette usersc 838 49.2 [39.7, 58.6] 97 809 5.0 [4.4, 5.5] 50 834 22.4 [18.4, 26.4] 64 840 4.9 [4.2, 5.6] 60

CI = confidence interval; NAT = N′-nitrosoanatabine; NAB = N′-nitrosoanabasine; NNAL = 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; NNN = N′-nitrosonornicotine; PATH = Population Assessment of Tobacco and Health; TSNA = tobacco-specific nitrosamine. DR: percentage of results greater than or equal to limit of detection (LOD). Every day established exclusive cigarette users: current users who are both established and every day users of only cigarettes; not using any other tobacco products. Intermittent exclusive cigarette users: current experimental/some day users of only cigarettes; not using any other tobacco products.

a

DR is less than 40%.

b

Relative standard error (RSE) is more than 30%. The RSE is calculated by 100 × standard error (estimate)/estimate.

c

Cigarette user groups are just for reference groups which are not included in other tables.